https://www.biopharmawatch.com/news/BYSI/beyondspring-reports-q2-2026-results-and-update BiopharmaWatch en 2026-08-14T21:15:00.000Z BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update https://www.biopharmawatch.com/news/RVP/retractable-technologies-q2-2026-results BiopharmaWatch en 2026-08-14T21:12:00.000Z Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026 https://www.biopharmawatch.com/news/ATNM/actinium-pharmaceuticals-actimab-a-advances-nyse-update BiopharmaWatch en 2026-08-14T21:02:00.000Z Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update https://www.biopharmawatch.com/news/SLN/silence-therapeutics-upsized-public-offering BiopharmaWatch en 2026-08-14T20:55:00.000Z Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs https://www.biopharmawatch.com/news/OPTH/optimi-health-discretionary-equity-facility BiopharmaWatch en 2026-08-14T20:55:00.000Z Optimi Health Establishes Discretionary Equity Facility https://www.biopharmawatch.com/news/CTOR/citius-oncology-fiscal-q3-2026-results BiopharmaWatch en 2026-08-14T20:30:00.000Z Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update https://www.biopharmawatch.com/news/CTXR/citius-pharmaceuticals-fiscal-third-quarter-2026-update BiopharmaWatch en 2026-08-14T20:30:00.000Z Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update https://www.biopharmawatch.com/news/PROF/profound-medical-announces-management-change BiopharmaWatch en 2026-08-14T20:30:00.000Z Profound Medical Announces Management Change https://www.biopharmawatch.com/news/TRAW/traws-pharma-q2-2026-financial-results-business-highlights BiopharmaWatch en 2026-08-14T20:30:00.000Z Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights